[1] [1] LABAY L M, BITTING C P, LEGG K M, et al. The determination of insulin overdose in postmortem investigations[J]. Acad Forensic Pathol, 2016, 6(2): 174−183. doi: 10.23907/2016.019.

[2] [2] STEPHENSON L, VAN DEN HEUVEL C, HUMPHRIES M, et al. Characteristics of fatal insulin overdoses[J]. Forensic Sci Med Pathol, 2022, 18(4): 429−441. doi: 10.1007/s12024-022-00511-3.

[3] [3] MANETTI A C, VISI G, SPINA F, et al. Insulin and oral hypoglycemic drug overdose in post-mortem investigations: A literature review[J]. Biomedicines, 2022, 10(11): 2823. doi: 10.3390/biomedicines10112823.

[4] [4] RZEPCZYK S, DOLISKA-KACZMAREK K, URUSKA A, et al. The other face of insulin-overdose and its effects[J]. Toxics, 2022, 10(3): 123. doi: 10.3390/toxics10030123.

[5] [5] RUSSELL K S, STEVENS J R, STERN T A. Insulin overdose among patients with diabetes: A readily available means of suicide[J]. Prim Care Companion J Clin Psychiatry, 2009, 11(5): 258−262. doi: 10.4088/PCC.09r00802.

[6] [6] LFMAN S, HAKKO H, MAINIO A, et al. Characteristics of suicide among diabetes patients: A population based study of suicide victims in Northern Finland[J]. J Psychosom Res, 2012, 73(4): 268−271. doi: 10.1016/j.jpsychores.2012.08.002.

[7] [7] BEHERA C, SWAIN R, MRIDHA A R, et al. Suicide by injecting lispro insulin with an intravenous cannula[J]. Med Leg J, 2015, 83(3): 147−149. doi: 10.1177/0025817215573171.

[8] [8] HAIBACH H, DIX J D, SHAH J H. Homicide by insulin administration[J]. J Forensic Sci, 1987, 32(1): 208−216.

[9] [9] MARKS V. Murder by insulin: Suspected, purported and proven — A review[J]. Drug Test Anal, 2009, 1(4): 162−176. doi: 10.1002/dta.38.

[10] [10] GREEN R P, HOLLANDER A S, THEVIS M, et al. Detection of surreptitious administration of analog insulin to an 8-week-old infant[J]. Pediatrics, 2010, 125(5): e1236−e1240. doi: 10.1542/peds.2009-2273.

[11] [11] JONES A W. Insulin murder and the case of Colin Norris[J]. J Forensic Leg Med, 2023, 94: 102483. doi: 10.1016/j.jflm.2023.102483.

[12] [12] HAWTON K, CLEMENTS A, SIMKIN S, et al. Doctors who kill themselves: A study of the methods used for suicide[J]. QJM, 2000, 93(6): 351−357. doi: 10.1093/qjmed/93.6.351.

[13] [13] HOLT R I G, SNKSEN P H. Growth hormone, IGF-I and insulin and their abuse in sport[J]. Br J Pharmacol, 2008, 154(3): 542−556. doi: 10.1038/bjp.2008.99.

[14] [14] EROTOKRITOU-MULLIGAN I, HOLT R I. Insulin-like growth factor I and insulin and their abuse in sport[J]. Endocrinol Metab Clin North Am, 2010, 39(1): 33−43, viii. doi: 10.1016/j.ecl.2009.10.003.

[15] [15] GREEN G A. Insulin as an anabolic drug of abuse in sport?[J]. Diabetes Technol Ther, 2004, 6(3): 387−388. doi: 10.1089/152091504774198098.

[16] [16] ANDERSON L J, TAMAYOSE J M, GARCIA J M. Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects[J]. Mol Cell Endocrinol, 2018, 464: 65−74. doi: 10.1016/j.mce.2017.06.010.

[17] [17] SUN Y M, KAMEL Y, AMIN R, et al. Intentional insulin overdose for euphoric experience[J]. Prim Care Companion CNS Disord, 2017, 19(6): 17102101. doi: 10.4088/PCC.17102101.

[18] [18] KOLB H, KEMPF K, RHLING M, et al. Insulin: Too much of a good thing is bad[J]. BMC Med, 2020, 18(1): 224. doi: 10.1186/s12916-020-01688-6.

[19] [19] MUSSHOFF F, HESS C, MADEA B. Disorders of glucose metabolism: Post mortem analyses in forensic cases — Part Ⅱ[J]. Int J Legal Med, 2011, 125(2): 171−180. doi: 10.1007/s00414-010-0510-0.

[20] [20] TONG F, WU R, HUANG W, et al. Forensic aspects of homicides by insulin overdose[J]. Forensic Sci Int, 2017, 278: 9−15. doi: 10.1016/j.forsciint.2017.06.015.

[21] [21] RENO C M, SKINNER A, BAYLES J, et al. Severe hypoglycemia-induced sudden death is mediated by both cardiac arrhythmias and seizures[J]. Am J Physiol Endocrinol Metab, 2018, 315(2): E240−E249. doi: 10.1152/ajpendo.00442.2017.

[22] [22] MURAD M H, COTO-YGLESIAS F, WANG A T, et al. Clinical review: Drug-induced hypoglycemia: A systematic review[J]. J Clin Endocrinol Metab, 2009, 94(3): 741−745. doi: 10.1210/jc.2008-1416.

[23] [23] WATKINS P J, THOMAS P K. Diabetes mellitus and the nervous system[J]. J Neurol Neurosurg Psychiatry, 1998, 65(5): 620−632. doi: 10.1136/jnnp.65.5.620.

[24] [24] JOHANSEN N J, CHRISTENSEN M B. A systematic review on insulin overdose cases: Clinical course, complications and treatment options[J]. Basic Clin Pharmacol Toxicol, 2018, 122(6): 650−659. doi: 10.1111/bcpt.12957.

[27] [27] WUNDER C, KAUERT G F, TOENNES S W. Factors leading to the degradation/loss of insulin in postmortem blood samples[J]. Forensic Sci Int, 2014, 241: 173−177. doi: 10.1016/j.forsciint.2014.06.003.

[28] [28] PALMIERE C, SABATASSO S, TORRENT C, et al. Post-mortem determination of insulin using chemiluminescence enzyme immunoassay: Preliminary results[J]. Drug Test Anal, 2015, 7(9): 797−803. doi: 10.1002/dta.1775.

[29] [29] MARKS V, WARK G. Forensic aspects of insulin[J]. Diabetes Res Clin Pract, 2013, 101(3): 248−254. doi: 10.1016/j.diabres.2013.05.002.

[30] [30] SHAHANI S, SHAHANI L. Use of insulin in diabetes: A century of treatment[J]. Hong Kong Med J, 2015, 21(6): 553−559. doi: 10.12809/hkmj154557.

[31] [31] SUNDERLAND N, WONG S, LEE C K. Fatal insulin overdoses: Case report and update on testing methodology[J]. J Forensic Sci, 2016, 61(S1): 281−284. doi: 10.1111/1556-4029.12958.

[32] [32] SASSO F C, RINALDI L, LASCAR N, et al. Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes[J]. J Diabetes Res, 2018, 2018: 3106056. doi: 10.1155/2018/3106056.

[33] [33] BORER-WEIR K E, BAILEY S R, MENZIES-GOW N J, et al. Evaluation of a commercially available radioimmunoassay and species-specific ELISAs for measurement of high concentrations of insulin in equine serum[J]. Am J Vet Res, 2012, 73(10): 1596−1602. doi: 10.2460/ajvr.73.10.1596.

[34] [34] ARBOUCHE N, MACOIN E, RAUL J S, et al. Influence of preservatives on insulin in postmortem blood: Application to a case of insulin aspart suicide[J]. J Anal Toxicol, 2023, 46(9): e300−e306. doi: 10.1093/jat/bkac094.

[35] [35] IWASE H, KOBAYASHI M, NAKAJIMA M, et al. The ratio of insulin to C-peptide can be used to make a forensic diagnosis of exogenous insulin overdosage[J]. Forensic Sci Int, 2001, 115(1/2): 123−127. doi: 10.1016/s0379-0738(00)00298-x.

[36] [36] MATHIEU C, GILLARD P, BENHALIMA K. Insulin analogues in type 1 diabetes mellitus: Getting better all the time[J]. Nat Rev Endocrinol, 2017, 13(7): 385−399. doi: 10.1038/nrendo.2017.39.

[37] [37] BVALOT F, CARTISER N, BOTTINELLI C, et al. State of the art in bile analysis in forensic toxicology[J]. Forensic Sci Int, 2016, 259: 133−154. doi: 10.1016/j.forsciint.2015.10.034.

[38] [38] OJANPER I, SAJANTILA A, VINOGRADOVA L, et al. Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS[J]. Forensic Sci Int, 2013, 233(1/2/3): 328−332. doi: 10.1016/j.forsciint.2013.10.009.

[39] [39] BECKETT N, TIDY R, DOUGLAS B, et al. Detection of intact insulin analogues in post-mortem vitreous humour — Application to forensic toxicology casework[J]. Drug Test Anal, 2021, 13(3): 604−613. doi: 10.1002/dta.2974.

[40] [40] BOTTINELLI C, CARTISER N, BVALOT F, et al. Is insulin intoxication still the perfect crime? Analysis and interpretation of postmortem insulin: Review and perspectives in forensic toxicology[J]. Crit Rev Toxicol, 2020, 50(4): 324−347. doi: 10.1080/10408444.2020.1762540.

[41] [41] DARBY S M, MILLER M L, ALLEN R O, et al. A mass spectrometric method for quantitation of intact insulin in blood samples[J]. J Anal Toxicol, 2001, 25(1): 8−14. doi: 10.1093/jat/25.1.8.

[42] [42] JUDK P, COPPIETERS G, LAPAUW B, et al. Urinary detection of rapid-acting insulin analogs in healthy humans[J]. Drug Test Anal, 2020, 12(11/12): 1629−1635. doi: 10.1002/dta.2817.

[43] [43] COX H D, KNUSSMANN G N, MOORE C, et al. Detection of insulin analogues and large peptides >2 kDa in urine[J]. Drug Test Anal, 2022, 14(7): 1264−1272. doi: 10.1002/dta.3249.

[44] [44] NAGASAWA S, YAMAGUCHI R, CHIBA F, et al. Identification, measurement, and evaluation of blood concentrations of insulin glargine and insulin lispro by UPLC-MS-MS in a dead body suspected of insulin overdose[J]. J Forensic Sci, 2023, 68(2): 704−710. doi: 10.1111/1556-4029.15219.

[45] [45] ARBOUCHE N, WALCH A, RAUL J S, et al. Intentional overdose of glargine insulin: Determination of the parent compound in postmortem blood by LC-HRMS[J]. J Forensic Sci, 2023, 68(3): 1077−1083. doi: 10.1111/1556-4029.15247.

[46] [46] VAN DEN OUWELAND J M W, KEMA I P. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 883−884: 18−32. doi: 10.1016/j.jchromb.2011.11.044.

[50] [50] COOK P R, GLENN C, ARMSTON A. Effect of hemolysis on insulin determination by the Beckman Coulter Unicell DXI 800 immunoassay analyzer[J]. Clin Biochem, 2010, 43(6): 621−622. doi: 10.1016/j.clinbiochem.2010.01.002.

[51] [51] GARINET S, FELLAHI S, MARLIN G, et al. Differential interferences of hemoglobin and hemolysis on insulin assay with the Abbott Architect®-Ci8200 immunoassay[J]. Clin Biochem, 2014, 47(6): 445−447. doi: 10.1016/j.clinbiochem.2014.01.026.

[52] [52] CHEN Z, CAULFIELD M P, MCPHAUL M J, et al. Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory[J]. Clin Chem, 2013, 59(9): 1349−1356. doi: 10.1373/clinchem.2012.199794.

[53] [53] TAYLOR S W, CLARKE N J, CHEN Z H, et al. A high-throughput mass spectrometry assay to simultaneously measure intact insulin and C-peptide[J]. Clin Chim Acta, 2016, 455: 202−208. doi: 10.1016/j.cca.2016.01.019.

[54] [54] THOMAS A, THEVIS M, DELAHAUT P, et al. Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes[J]. Anal Chem, 2007, 79(6): 2518−2524. doi: 10.1021/ac062037t.

[55] [55] LEGG K M, LABAY L M, AIKEN S S, et al. Validation of a fully automated immunoaffinity work-flow for the detection and quantification of insulin analogs by LC-MS-MS in postmortem vitreous humor[J]. J Anal Toxicol, 2019, 43(7): 505−511. doi: 10.1093/jat/bkz014.

[56] [56] REDMON J B, NUTTALL F Q. Autoimmune hypoglycemia[J]. Endocrinol Metab Clin N Am, 1999, 28(3): 603−618. doi: 10.1016/S0889-8529(05)70090-6.

[57] [57] DE LEN D D, STANLEY C A. Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(6): 763−769. doi: 10.1016/j.beem.2013.06.005.

[58] [58] BOWSHER R R, NOWATZKE W L. Insights in regulated bioanalysis of human insulin and insulin analogs by immunoanalytical methods[J]. Bioanalysis, 2011, 3(8): 883−898. doi: 10.4155/bio.11.50.

[59] [59] HESS C, MADEA B, DALDRUP T, et al. Determination of hypoglycaemia induced by insulin or its synthetic analogues post mortem[J]. Drug Test Anal, 2013, 5(9/10): 802−807. doi: 10.1002/dta.1500.

[60] [60] CROFTS C, SCHOFIELD G, ZINN C, et al. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: An examination of the Kraft database[J]. Diabetes Res Clin Pract, 2016, 118: 50−57. doi: 10.1016/j.diabres.2016.06.007.

[61] [61] KERNBACH-WIGHTON G, PSCHEL K. On the phenomenology of lethal applications of insulin[J]. Forensic Sci Int, 1998, 93(1): 61−73. doi: 10.1016/S0379-0738(98)00032-2.

[62] [62] DICKSON S J, CAIRNS E R, BLAZEY N D. The isolation and quantitation of insulin in post-mortem specimens — A case report[J]. Forensic Sci, 1977, 9(1): 37−42. doi: 10.1016/0300-9432(77)90063-2.

[63] [63] MARKS V. Insulin murders[J]. Med Leg J, 2009, 77(2): 39−47. doi: 10.1258/rsmmlj.77.2.39.

[64] [64] IKEDA T, TANI N, HIROKAWA T, et al. Biodistribution of insulin following massive insulin subcutaneous injection[J]. Intern Med, 2022, 61(13): 1999−2006. doi: 10.2169/internalmedicine.7364-21.

[65] [65] SKOWRONEK R, NOWICKA J, CZECH E, et al. Evaluation of the usefulness of the immunoradiometric method for post-mortem measurement of insulin concentration in the intraocular fluid: Preliminary results[J]. Arch Med Sadowej Kryminol, 2018, 68(3): 161−170. doi: 10.5114/amsik.2018.83093.

[66] [66] WINSTON D C. Suicide via insulin overdose in nondiabetics: The New Mexico experience[J]. Am J Forensic Med Pathol, 2000, 21(3): 237−240. doi: 10.1097/00000433-200009000-00010.

[67] [67] SCARLETT J A, MAKO M E, RUBENSTEIN A H, et al. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies[J]. N Engl J Med, 1977, 297(19): 1029−1032. doi: 10.1056/NEJM197711102971903.

[68] [68] BELSEY S L, FLANAGAN R J. Postmortem biochemistry: Current applications[J]. J Forensic Leg Med, 2016, 41: 49−57. doi: 10.1016/j.jflm.2016.04.011.

[69] [69] BUGELLI V, CAMPOBASSO C P, ANGELINO A, et al. CLEIA of humor vitreous in a case of suicidal insulin overdose[J]. Leg Med (Tokyo), 2019, 40: 22−25. doi: 10.1016/j.legalmed.2019.06.007.

[70] [70] ZHAO S, LIU Z, MA L, et al. Potential biomarkers in hypoglycemic brain injury[J]. Forensic Sci Med Pathol, 2024, 20(3): 810−822. doi: 10.1007/s12024-023-00681-8.

[71] [71] WARD L J, ENGVALL G, GREEN H, et al. Postmortem metabolomics of insulin intoxications and the potential application to find hypoglycemia-related deaths[J]. Metabolites, 2022, 13(1): 5. doi: 10.3390/metabo13010005.

[72] [72] BIAN C, HE X, WANG Q, et al. Biochemical toxicological study of insulin overdose in rats: A forensic perspective[J]. Toxics, 2023, 12(1): 17. doi: 10.3390/toxics12010017.